🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.34
-0.43 (-6.35%)
At close: Nov 19, 2026, 4:00 PM EST
6.26
-0.08 (-1.34%)
After-hours: Nov 19, 2026, 7:30 PM EST

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $1.22M in the quarter ending September 30, 2026, a decrease of -64.55%. This brings the company's total for the last twelve months to $3.97M, down -97.39% year-over-year. In the year 2025, Atara Biotherapeutics had annual revenue of $120.77M, down -6.33%. That makes Atara Biotherapeutics the 40,718th largest company in the world by revenue and 5,443rd in the United States.

Revenue (ttm)
$3.97M
Revenue Growth
-97.39%
P/S Ratio
16.21
Revenue / Employee
$396,500
Employees
10
Market Cap
64.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025120.77M-8.17M-6.33%
Dec 31, 2024128.94M120.37M1,404.02%
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Gossamer Bio78.42M
Champions Oncology60.66M
NeurAxis6.53M
Nutriband1.62M
MediciNova935.72K
Cardiff Oncology559.00K
Revenue Rankings